IFP Advisors’s Petros Pharmaceuticals PTPI Stock Holding History

IFP Advisors’s Portfolio PTPI Stock Details PTPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3	Closed	-$2.83K	–	3180
2020 Q4	$4K	Buy	+3	New	+$2.82K	﹤0.01%	2422

Other funds holding PTPI

NorthRock Partners Minneapolis, Minnesota $6.2B AUM 15.8% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFAS

Acorn Financial Advisory Services Reston, Virginia $753M AUM 36.94% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

NRS

Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

IFP Advisors's PTPI Position: Q1 2021 in Review

IFP Advisors sold out of Petros Pharmaceuticals (PTPI) in Q1 2021, closing a stake of 3 shares — an estimated $2.83K sold.

IFP Advisors first reported a position in PTPI in Q4 2020 and held it in 1 quarter. The position peaked at $4K in Q4 2020. 17 funds tracked by Wall St. Rank hold PTPI as of Q1 2021.

IFP Advisors reported no remaining Petros Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
IFP Advisors sold 3 Petros Pharmaceuticals shares in Q1 2021, an estimated $2.83K.
IFP Advisors first reported a position in Petros Pharmaceuticals in Q4 2020 and held it in 1 quarter.
IFP Advisors's Petros Pharmaceuticals position peaked at $4K in Q4 2020.
17 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q1 2021.

Based on IFP Advisors's 13F filing for Q1 2021, filed 30 Apr 2021.